Glenmark
Covid-19 crisis: Briton Pharma gets DCGI nod to launch favipiravir
Glenmark gets DCGI notice over 'false claims', price of Covid drug FabiFlu
Glenmark cuts price of Covid drug FabiFlu by 27% within a month of launch
US charges generic drug firm Glenmark with conspiracy in price-fixing
Coronavirus vaccine update: Moderna vaccine trial delayed, India's by Aug15

India's coronavirus drug market set for price war as firms ready launches
Can't call Remdesiver, Favipiravir game changers in Covid-19 fight: Experts
Coronavirus vaccine update: AstraZeneca, Modena leading the race, says WHO
Glenmark gets DCGI nod for clinical trials of potential Covid-19 drug
India gears up for patient trials on 20 different drugs for Covid-19

Strong outlook, attractive valuations driving Glenmark's bounce back
Hindustan Unilever, GSK Consumer stocks hit lifetime highs ahead of merger
Glenmark gets tentative nod from USFDA for generic type-2 diabetes tablets
More drug licensing deals will play a big part in paring Glenmark's debt
Glenmark Pharma Q3 consolidated net profit rises 64% to Rs 190.83 crore
Glenmark gets US FDA nod for tablet used to treat high levels of iron
Glenmark gets approval from Australian regulator to commercialise Ryaltris
Glenmark Pharma gets tentative nod from USFDA for multiple sclerosis drug
Glenmark stock tumbles to 52-week low on USFDA warning letter to Baddi unit
USFDA warning letter for Glenmark's Baddi unit, reason classified